AI Verdict
NMAX has stronger fundamentals based on our AI analysis.
NMAX vs NKTR Fundamental Comparison
| Metric | NMAX | NKTR |
|---|---|---|
| Revenue | $189.3M | $55.2M |
| Net Income | $-99.5M | $-164.1M |
| Net Margin | -52.6% | -297.1% |
| ROE | -93.8% | -182.6% |
| ROA | -41.5% | -58.5% |
| Current Ratio | 2.40x | 4.97x |
| Debt/Equity | 0.00x | 1.49x |
| EPS | $-0.96 | $-9.73 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
NMAX vs NKTR: Frequently Asked Questions
Is NMAX or NKTR a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), NMAX has stronger fundamentals. NMAX is rated STRONG SELL (96% confidence) while NKTR is rated STRONG SELL (92% confidence). This is not investment advice.
How does NMAX compare to NKTR fundamentally?
Newsmax Inc. has ROE of -93.8% vs NEKTAR THERAPEUTICS's -182.6%. Net margins are -52.6% vs -297.1% respectively.
Which stock pays higher dividends, NMAX or NKTR?
NMAX has a dividend yield of N/A or no dividend while NKTR has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in NMAX or NKTR for long term?
For long-term investing, consider that NMAX has STRONG SELL rating with 96% confidence, while NKTR has STRONG SELL rating with 92% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about NMAX vs NKTR?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For NMAX vs NKTR, the AI consensus favors NMAX based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.